News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>UBS Envisions INNOVENT BIO's Partnership with Eli Lilly to Provide Upside for Drug Advancement Targets
INNOVENT BIO (01801.HK) and Eli Lilly and Company (LLY.US) have entered into a collaboration on multiple early-stage oncology and immunology assets, according to a UBS research rep...
Reset
Send
The window will close in 5 seconds
<Research>UBS Envisions INNOVENT BIO's Partnership with Eli Lilly to Provide Upside for Drug Advancement Targets
Close
Recommend
5
Positive
8
Negative
1
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

INNOVENT BIO (01801.HK)  +0.600 (+0.660%)    Short selling $398.18M; Ratio 95.618%   and Eli Lilly and Company (LLY.US)      have entered into a collaboration on multiple early-stage oncology and immunology assets, according to a UBS research report.

The agreement includes an upfront payment of USD350 million, potential milestone payments up to USD8.5 billion, and tiered royalties based on net sales.

Related News CMBI Slightly Raises TP for INNOVENT BIO (01801.HK) to HKD113.86, Accelerating Global Biopharmaceutical Transformation
UBS not only favored the seventh collaboration between the two companies, but it also saw this collaboration as a new model of partnership compared to previous out-licensing deals, as it involves the establishment of a new company and joint development.

More importantly, UBS observed that the potential assets include new ones not previously seen in INNOVENT BIO's R&D pipeline, which could provide upside potential for the company's original guidance to advance 8-10 candidate drugs into clinical stages every year.

UBS has given INNOVENT BIO a target price of HKD137.4 and a Buy rating.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.